ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 38 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,000 | +50.0% | 1,666 | 0.0% | 0.01% | +37.5% |
| Q2 2022 | $8,000 | -11.1% | 1,666 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $9,000 | -10.0% | 1,666 | 0.0% | 0.01% | -11.1% |
| Q4 2021 | $10,000 | -33.3% | 1,666 | 0.0% | 0.01% | -30.8% |
| Q3 2021 | $15,000 | +15.4% | 1,666 | 0.0% | 0.01% | +18.2% |
| Q2 2021 | $13,000 | – | 1,666 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sentinus, LLC | 149,050 | $1,408,523 | 0.47% |
| Intrepid Financial Planning Group LLC | 19,000 | $179,550 | 0.09% |
| PERRITT CAPITAL MANAGEMENT INC | 12,000 | $113,400 | 0.06% |
| Interchange Capital Partners, LLC | 11,413 | $107,853 | 0.06% |
| Virtu Financial LLC | 21,650 | $205 | 0.02% |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 15,000 | $141,750 | 0.02% |
| J. Goldman & Co LP | 42,228 | $399,055 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 63,966 | $604,479 | 0.02% |
| KENNEDY CAPITAL MANAGEMENT LLC | 46,311 | $437,639 | 0.01% |
| 683 Capital Management, LLC | 16,000 | $151,200 | 0.01% |